TL;DR
Get workout gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
MedPage Today published an October 18, 2026, roundup of comments from clinicians and researchers on healthcare technology, vaccine access, study findings and patient care. The quotes highlight questions raised by the work, but the roundup itself does not provide the underlying studies’ methods or full results.
MedPage Today published a weekly roundup on October 18, 2026, collecting comments from clinicians and researchers on artificial intelligence in healthcare, access to an mRNA flu shot and findings across several areas of medicine. The excerpts offer a snapshot of issues raised in the publication’s reporting, but do not provide enough detail to establish the evidence or recommendations behind each topic.
The roundup opens with Mishal Khan, PhD, of the UC Berkeley Labor Center, describing AI’s role in healthcare as neither inherently good nor bad, but also not neutral. The comment frames technology as something whose effects depend on how it is designed and used. The item does not specify a particular AI system, study or policy proposal.
On vaccine access, Amesh Adalja of the Johns Hopkins Center for Health Security said people seeking the new mRNA flu shot, referred to in the roundup as mFlusiva, would need to use a website or call providers. The brief excerpt does not identify the website, explain eligibility, or describe where doses are available.
Other comments address distinct research and clinical issues. Krista Huybrechts of Brigham and Women’s Hospital called findings on benzodiazepine use early in pregnancy reassuring while cautioning that the drugs are not risk-free. Ahmed Zayed of Staten Island University Hospital said pulmonary vascular resistance should not be interpreted in isolation when considering heart-transplant outcomes. The roundup also includes comments on sickle cell disease and cancer risk, advanced HIV, pediatric obesity screening, and plastic surgery.
Access and Evidence Across Care
The roundup brings together comments that point to practical questions behind medical headlines: who can access a treatment, how research findings should be interpreted, and whether clinical measures capture a patient’s broader health. Those questions matter to patients and clinicians weighing care options, as well as to policymakers considering how technology and services are organized.
The excerpts are not a substitute for the original research or reporting. For example, Huybrechts’s wording balances reassurance with a safety caveat, while Zayed’s comment urges readers not to rely on one measure alone. Neither statement supplies the study data needed to judge the size of any risk or the strength of an association. The roundup’s value is in identifying themes and directing attention to the underlying stories.
As an affiliate, we earn on qualifying purchases.
Eight Topics in One Roundup
MedPage Today presented the item as a collection of quotes heard by its reporters, rather than as a single study or policy announcement. The page is dated October 18, 2026 and describes the roundup as a two-minute read. Its eight excerpts cover healthcare AI; access to an mRNA flu shot; the television program “The Swan” and plastic surgery; benzodiazepine use in early pregnancy; pulmonary vascular resistance after heart transplantation; cancer risk among people with sickle cell disease; long-acting HIV therapy; and screening for pediatric obesity.
The comments come from people with different roles and affiliations, including academic researchers, physicians and professional organizations. They refer to underlying reporting or research, but the supplied roundup does not give study titles, publication dates, sample sizes, methods or full results. Each quote therefore needs to be read in its own subject area, not as evidence for one shared conclusion.
“Tech is not good or bad, but neither is it neutral.”
— Mishal Khan, PhD, UC Berkeley Labor Center
As an affiliate, we earn on qualifying purchases.
Study Details Are Not Included
The roundup does not state the methods, populations, effect sizes or limitations of the studies it references. It is therefore not possible from these excerpts alone to assess the evidence behind the comments on pregnancy outcomes, transplant measures, cancer risk, HIV treatment or obesity screening.
Practical details about mFlusiva also remain unspecified, including the website Adalja referenced, eligibility, supply and how access varies by location. The AI comment is similarly broad: no specific tool, deployment or measurable outcome is identified. The article does not say whether the quoted experts’ comments represent formal findings, personal interpretations or recommendations beyond the wording provided.
pregnancy benzodiazepine safety guide
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Follow the Underlying Reports
Readers seeking clinical or policy implications will need to consult the individual MedPage Today reports and cited studies, where available, for methods, results and expert context. For those looking for mFlusiva, the roundup points to checking the referenced website or contacting providers, but does not supply a direct link or confirm current stock.
No single next milestone is announced in the weekly item. Further clarity depends on the underlying research and reporting, including details on study findings, treatment access and how the experts’ observations apply to patients. Until then, the quotes should be treated as brief commentary, not stand-alone clinical guidance.
heart transplant pulmonary vascular resistance monitor
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
What did MedPage Today publish?
It published a weekly roundup of quotes from its reporters’ coverage, dated October 18, 2026, on topics including healthcare AI, vaccine access and medical research.
What did the roundup say about AI in healthcare?
Mishal Khan of the UC Berkeley Labor Center said technology is neither inherently good nor bad, but is not neutral. The excerpt does not identify a specific AI system or study.
Does the item explain how to get mFlusiva?
Not in detail. Amesh Adalja said people seeking the mRNA flu shot would need to use a website or call around, but the roundup does not name the website or confirm eligibility or availability.
Does the roundup provide enough information to judge the studies?
No. It gives short comments but not the methods, sample sizes or full results of the research discussed. The original reports and studies are needed for that assessment.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
